Regulacion, Baby Girl .
HRN: 21-58-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
CEFOTAXIME 500MG (VIAL)
07/15/2022
07/21/2022
IVT
150mg
Q12
Psnb (thickly Meconium Amniotic Fluid, Infected Umbilical Cord)
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes